Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: METROGEL-VAGINAL

« Back to Dashboard
Metrogel-vaginal is a drug marketed by Medicis and is included in one NDA. It is available from six suppliers.

The generic ingredient in METROGEL-VAGINAL is metronidazole. There are eighteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

Summary for Tradename: METROGEL-VAGINAL

Suppliers / Packagers: see list7

Pharmacology for Tradename: METROGEL-VAGINAL

Clinical Trials for: METROGEL-VAGINAL

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis
Status: Completed Condition: Clostridium Difficile Associated Diarrhea

Penicillin and Metronidazole in Treatment of Peritonsillar Abscess
Status: Completed Condition: Peritonsillar Abscess

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately
Status: Completed Condition: Healthy

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
Status: Completed Condition: Bacterial Vaginosis

Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies
Status: Recruiting Condition: Abnormal Vaginal Flora; Clindamycin Vs Metronidazole; High Risk Pregnancies for Preterm Labor

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
Status: Recruiting Condition: Clostridium Difficile Diarrhea

Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy
Status: Completed Condition: Hemorrhoids

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease
Status: Recruiting Condition: Crohn's Disease

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections
Status: Not yet recruiting Condition: Bacterial Vaginosis; Fungal Vaginal Infections

A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
Status: Completed Condition: Intra-abdominal Infections

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GEL;VAGINAL020208-001Aug 17, 1992RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: METROGEL-VAGINAL

Drugname Dosage Strength RLD Submissiondate
metronidazoleVaginal Gel0.75%MetroGel-Vaginal9/2/2004
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn